65,437 trials
H1N1 Influenza Healthy Volunteers
Primary: Area Under the Curve (AUC) of Viral Shedding — 48.56; 25.53 ViralLoad(log(copies/ml))per time(hours) — p=0.31
Cervical Cancer · Uterine Endometrial Cancer · Ovarian Cancer
Primary: Hospital Stay — 3.0; 3.0 Days — p=0.36
DiGeorge Anomaly · Complete DiGeorge Anomaly · Complete Atypical DiGeorge Anomaly
Primary: Survival at 1 Year Post-CTTI — 71 % of participants who survive to 1 year
Optical Properties of Laminate Veneers
Primary: Optical Properties of Laminate Veneers — 5.31; 5.07 Delta E (color change)
Peripheral Vascular Disease · Intermittent Claudication
Primary: Maximum Walking Distances — 147; 68 Meters
Safety Issues
Primary: Number of Participants With Treatment-Emergent Adverse Events (TEAEs) — 0; 0; 2; 1 Participants
Metastatic Epidural Spinal Cord Compression
Primary: Number of Participants Showing Improvement or no Further Progression of Motor Deficits at 1 Month Following Radiotherapy — 68; 69 Participants
Post Traumatic Stress Disorder · Mild Traumatic Brain Injury, Concussion
Primary: Change in Performance on Neurocognitive Measure of Attention and Executive Function Post GOALS Intervention vs EDU Control Training — -0.03; -0.39 z score — p=<0.01
Heart Failure
Primary: Biologic Efficacy: Inflammation Marker - C-Reactive Protein — 2.5; 0.6; 0.6 mg/dL
Hepatocellular Carcinoma
Primary: Progression-Free Survival (PFS) Per Response Evaluation Criteria in Solid Tumors Version 1.1 (RECIST 1.1) — 3.0; 2.8 Months — p=0.0186
Rheumatoid Arthritis
Primary: Area Under the Concentration Time Cure From Time 0 to Last Quantifiable Concentration (AUC0-t) — 144500; 151600; 154600 h*µg/mL
Diabetes · Diabetes Mellitus, Type 2
Primary: Change in HbA1c — -0.9; -1.3; -1.5; -0.3 Percentage of HbA1c — p=<0.0001
DiGeorge Anomaly · DiGeorge Syndrome · Complete DiGeorge Anomaly
Primary: Survival at 1 Year Post-CTTI — 83 % of participants who survive to 1 year
Diabetes · Diabetes Mellitus, Type 2
Primary: Participants Who Achieve HbA1c <7.0% (53 mmol/Mol) ADA Target (Yes/no) — 134; 60; 96; 178 Participants — p=<0.0001
Pancreatic Cancer
Primary: Sustained Biliary Drainage, Defined as Absence of Reinterventions for the Management of Biliary Obstructive Symptoms — 39; 43 Participants — p=<0.01